{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:22:29Z","timestamp":1773865349589,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.nefroe.2026.501444","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:27:16Z","timestamp":1771504036000},"page":"501444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lecithin-cholesterol acyltransferase deficiency with the finding of \u201czebra bodies\u201d: A diagnostic challenge in the context of suspected Fabry disease"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9794-0327","authenticated-orcid":false,"given":"Juan Enrique","family":"Rodriguez Mori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2072-525X","authenticated-orcid":false,"given":"Milagros del Pilar","family":"Dapello Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9505-3783","authenticated-orcid":false,"given":"Julia","family":"Sumire Umeres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8653-8906","authenticated-orcid":false,"given":"Roxana Maybor","family":"Lipa Chancolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2026.501444_bib0005","article-title":"A systematic review of the natural history and biomarkers of primary lecithin: cholesterol acyltransferase deficiency","volume":"63.3","author":"Vitali","year":"2022","journal-title":"J Lipid Res [Internet]"},{"key":"10.1016\/j.nefroe.2026.501444_bib0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.athplu.2023.04.001","article-title":"HDL and chronic kidney disease","volume":"52","author":"Pavanello","year":"2023","journal-title":"Atherosclerosis Plus [Internet]"},{"issue":"7\u20138","key":"10.1016\/j.nefroe.2026.501444_bib0015","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.clinbiochem.2014.08.014","article-title":"A review on lecithin: Cholesterol acyltransferase deficiency","volume":"48","author":"Saeedi","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/j.nefroe.2026.501444_bib0020","first-page":"286","article-title":"Lecithin-cholesterol acyltransferase deficiency: a review for clinical nephrologists","volume":"31","author":"Carmo","year":"2017","journal-title":"Port J Nephrol Hypert [Internet]"},{"key":"10.1016\/j.nefroe.2026.501444_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0150083","article-title":"Lipoprotein X causes renal disease in LCAT deficiency","volume":"11","author":"Ossoli","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.nefroe.2026.501444_bib0030","doi-asserted-by":"crossref","first-page":"15090","DOI":"10.1074\/jbc.M008466200","article-title":"Analysis of Glomerulosclerosis and Atherosclerosis in Lecithin Cholesterol Acyltransferase-deficient Mice","volume":"276","author":"Lambert","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nefroe.2026.501444_bib0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12882-017-0571-0","article-title":"Ultrastructural deposits appearing as \u201czebra bodies\u201d in renal biopsy: Fabry disease?- Comparative case reports","volume":"18","author":"De Menezes Neves","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.nefroe.2026.501444_bib0040","doi-asserted-by":"crossref","first-page":"679","DOI":"10.5551\/jat.RV17051","article-title":"Current status of familial lcat deficiency in japan","volume":"28","author":"Kuroda","year":"2021","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.nefroe.2026.501444_bib0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/13816818809031494","article-title":"Familial lecithin: cholesterol acyltransferase (LCAT) deficiency: an updated review spring 1988","volume":"9","author":"Gjone","year":"1988","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.nefroe.2026.501444_bib0050","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/MOL.0000000000000697","article-title":"Genetic, biochemical, and clinical features of LCAT deficiency: update for 2020","volume":"31","author":"Pavanello","year":"2020","journal-title":"Curr Opin Lipidol"},{"issue":"No. 3","key":"10.1016\/j.nefroe.2026.501444_bib0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0046-8177(82)80187-1","article-title":"Unusual Renal Biopsy findings in a patient with Familial Lecithin: Cholesterol","volume":"13","author":"Magil","year":"1982","journal-title":"Hum Pathol"},{"key":"10.1016\/j.nefroe.2026.501444_bib0060","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10157-013-0895-4","article-title":"Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiency","volume":"18","author":"Hirashio","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.nefroe.2026.501444_bib0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/01913123.2010.551578","article-title":"Lecithin: cholesterol acyltransferase (LCAT) deficiency: renal lesions with early graft recurrence","volume":"35","author":"Str\u00f8m","year":"2011","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.nefroe.2026.501444_bib0070","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1053\/j.ajkd.2015.08.006","article-title":"AJKD atlas of renal pathology: Fabry nephropathy","volume":"66.5","author":"Najafian","year":"2015","journal-title":"Am J Kidney Dis [Internet]"},{"key":"10.1016\/j.nefroe.2026.501444_bib0075","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.2169\/internalmedicine.0882-22","article-title":"Kidney Podocyte Zebra Bodies after Lung Transplantation for Lymphangioleiomyomatosis","volume":"62","author":"Ishide","year":"2023","journal-title":"Intern Med"},{"key":"10.1016\/j.nefroe.2026.501444_bib0080","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00467-020-04564-w","article-title":"Myelin bodies in LMX1B-associated nephropathy: potential for misdiagnosis","volume":"35","author":"Lei","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2026.501444_bib0085","doi-asserted-by":"crossref","first-page":"403","DOI":"10.23876\/j.krcp.22.027","article-title":"Zebra bodies in lupus nephritis after hydroxychloroquine therapy","volume":"42","author":"Singh","year":"2023","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.nefroe.2026.501444_bib0090","article-title":"IgA nephropathy with mimicking Fabry disease: a case report and literature review","volume":"42","author":"Sun","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.nefroe.2026.501444_bib0095","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1136\/bcr-2018-228876","article-title":"Hydroxychloroquine-induced podocytopathy mimicking Fabry disease","volume":"12","author":"Serre","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"Suppl 1","key":"10.1016\/j.nefroe.2026.501444_bib0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1590\/1806-9282.66.s1.10","article-title":"Fabry disease: genetics, pathology, and treatment","volume":"66","author":"Bernardes","year":"2020","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.nefroe.2026.501444_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mgg3.1666","article-title":"The benefits and challenges of family genetic testing in rare genetic diseases\u2014lessons from Fabry disease","volume":"9","author":"Germain","year":"2021","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.nefroe.2026.501444_bib0110","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jacl.2015.12.007","article-title":"Familial lecithin: cholesterol acyltransferase deficiency: first in-human treatment with enzyme replacement","volume":"10","author":"Shamburek","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.nefroe.2026.501444_bib0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOL.0000000000000673","article-title":"Novel lecithin: cholesterol acyltransferase-based therapeutic approaches","volume":"31","author":"Freeman","year":"2020","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.nefroe.2026.501444_bib0120","first-page":"356","article-title":"Familial lecithin cholesterol acyltransferase deficiency: First in-human treatment with enzyme replacement","volume":"10","author":"Shambuken","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.nefroe.2026.501444_bib0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOL.0000000000000673","article-title":"Novel lecithin cholesterol acyltransferase-based therapeutic approaches","volume":"31","author":"Freeman","year":"2020","journal-title":"Curr Opin Lipidol"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251426000477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251426000477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:55:31Z","timestamp":1773838531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251426000477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2013251426000477"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2026.501444","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lecithin-cholesterol acyltransferase deficiency with the finding of \u201czebra bodies\u201d: A diagnostic challenge in the context of suspected Fabry disease","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2026.501444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2025.501444","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501444"}}